Science and Enterprise

Category: Joint ventures/collaborations

  • Academic-Business Partnership Developing IVF Technology

    A reproductive biologist at University of Adelaide in Australia has discovered molecules in a mother’s tissue that can help women who have suffered previous miscarriages after in-vitro fertilization (IVF) improve their rates of subsequent IVF success. Professor Sarah Robertson (pictured right), who made the discovery, is partnering with a Danish company to develop a product…

  • Researchers to Study Hip Replacement, Jobs, Retirement

    Researchers in Italy, the U.K., and the U.S. will study the impact of hip replacement therapy on the employment and retirement decisions of older adults. The project with participants from Università Bocconi in Milan, University of York in the U.K., and Johns Hopkins University School of Public Health in Baltimore, Maryland is funded by a…

  • Partnership To Advance Military Field Energy Sources

    A team from Maxwell Technologies Inc. in San Diego, California, University of Massachusetts in Amherst, and the U.S. Navy will develop a lighter, longer-lasting, energy source for field radios and other portable electronic equipment carried by military personnel. Maxwell Technologies says today that Defense Advanced Research Projects Agency (DARPA) awarded the company a $1.7 million…

  • Pharma, Biotech Ink Deal on Anti-Inflammatory Candidate

    XOMA Ltd., a biotechnology company in Berkeley, California, and Les Laboratoires Servier a French pharmaceutical company, announced an agreement to develop and commercialize XOMA 052, XOMA’s anti-inflammatory drug candidate. XOMA 052 is designed to inhibit the pro-inflammatory cytokine interleukin-1 beta believed to be a primary trigger of pathologic inflammation in multiple diseases. Under the agreement,…

  • Biotech Licenses Natural Anti-Bacterial Compounds

    AMRI, a biotechnology company in Albany, New York agreed to a research and licensing deal with Genentech, a Roche Group company, for AMRI’s anti-bacterial compounds from its natural products sample collection. Under the agreement, Genentech will receive an exclusive license to develop and commercialize potential products from AMRI’s anti-bacterial program. AMRI will also collaborate with…

  • Collaboration Targets New Circulating Tumor Cell Technology

    Massachusetts General Hospital (MGH) in Boston and Veridex LLC, a biotechnology subsidiary of pharmaceutical company Johnson & Johnson  in Raritan, New Jersey said today they plan to develop and commercialize a technology for capturing, counting, and characterizing tumor cells found in patients’ blood. These circulating tumor cells (CTCs) are cancer cells that have detached from…

  • Team-Based Medical Care Shows Better Patient Outcomes

    Researchers at the University of Washington and Group Health Research Institute, both in Seattle, tested a primary care intervention where nurses worked with patients and health teams to manage care for depression and physical disease together, using evidence-based guidelines. The results from this randomized controlled trial showed for patients less depression; better control of blood…

  • Collaboration to Research Obesity Biomarkers, Drug Targets

    Florida Hospital in Orlando, Sanford-Burnham Medical Research Institute also in Orlando, and Takeda Pharmaceutical Company in Osaka, Japan, will collaborate on developing new therapies for obesity, a growing worldwide health problem. The partnership aims to to identify and validate new obesity-related biomarkers and molecular targets. The project is the first corporate-sponsored research undertaken by the…

  • Engineers Develop Biomarker Breathalyzer Diagnostics

    Researchers at Purdue University in West Lafayette, Indiana are developing breath-analysis technology to diagnose patients in real time by detecting chemical compounds called biomarkers in a person’s respiration. Carlos Martinez, an assistant professor of materials engineering leads the project for Purdue, and is working with colleagues at the National Institute of Standards and Technology, a…

  • International Team Sequences Criollo Cacao Genome

    Researchers from 18 institutions in five countries reported sequencing the genome of Theobroma cacao, commonly called the Criollo cacao tree. The findings are published in the current online issue of Nature Genetics. The tree is known for its high quality, but also for low productivity and weak resistance to disease. Most commercial chocolate today comes…